Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease

Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease

Ischemic heart disease (IHD), especially myocardial infarction (MI), is a leading cause of death worldwide. Although coronary reperfusion is the most straightforward treatment for limiting the MI size, it has nevertheless been shown to exacerbate ischemic myocardial injury. Therefore, identifying an...

Full description

Bibliographic Details
Main Author:	Erij Messadi
Format:	Article
Language:	English
Published:	MDPI AG 2023-10-01
Series:	Biomolecules
Subjects:	atherosclerosis biologically active molecules cardioprotection hypertension ischemic heart disease myocardial infarction
Online Access:	https://www.mdpi.com/2218-273X/13/10/1539

Similar Items

Capsaicin-Sensitive Sensory Nerves and the TRPV1 Ion Channel in Cardiac Physiology and Pathologies
by: Tamara Szabados, et al.
Published: (2020-06-01)

Ischemic postconditioning fails to reduce infarct size in pig models of intermediate and prolonged ischemia
by: Jorge Nuche, et al.
Published: (2023-02-01)

Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
by: Gerd Heusch, et al.
Published: (2023-11-01)

MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction
by: Elke Boxhammer, et al.
Published: (2023-09-01)

Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction
by: Paolo Severino, et al.
Published: (2020-10-01)

Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled Trial
by: Paul M. Haller, et al.
Published: (2020-07-01)

VEGF-A in Cardiomyocytes and Heart Diseases
by: Mariantonia Braile, et al.
Published: (2020-07-01)

COMPARATIVE ANALYSIS OF THE CALCULATION MODELS FOR ISCHEMIC HEART DISEASE OVERALL RISK IN RAILROAD WORKERS
by: S. G. Gorokhova, et al.
Published: (2016-06-01)

Thyroid and Heart: A Fatal Pathophysiological Attraction in a Controversial Clinical Liaison
by: Alessandro Pingitore, et al.
Published: (2023-11-01)

From Brain to Heart: Possible Role of Amyloid-β in Ischemic Heart Disease and Ischemia-Reperfusion Injury
by: Giulia Gagno, et al.
Published: (2020-12-01)

Lebetin 2, a Snake Venom-Derived B-Type Natriuretic Peptide, Provides Immediate and Prolonged Protection against Myocardial Ischemia-Reperfusion Injury via Modulation of Post-Ischemic Inflammatory Response
by: Bochra Tourki, et al.
Published: (2019-09-01)

Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction
by: Sabina Andreea Leancă, et al.
Published: (2023-04-01)

Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury
by: Wylly Ramsés García-Niño, et al.
Published: (2021-10-01)

Effect of exercise training on cardiac mitochondrial respiration, biogenesis, dynamics, and mitophagy in ischemic heart disease
by: Mary Audrey D. Viloria, et al.
Published: (2022-10-01)

A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
by: Pema Raj, et al.
Published: (2021-10-01)

Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia
by: Carolin Torregroza, et al.
Published: (2021-04-01)

Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart
by: Kristína Ferenczyová, et al.
Published: (2021-08-01)

A TRICk to Improve the Effectiveness of RIC: Role of Limb Temperature in Enhancing the Effectiveness of Remote Ischemic Conditioning
by: Claudia Penna, et al.
Published: (2022-01-01)

Pathogenetic stroke subtypes and their diagnostic criteria in patients with ischemic heart disease and intracranial atherosclerosis: a clinical-morphological study
by: Renat E. Ablyakimov, et al.
Published: (2017-02-01)

ISCHEMIC PRECONDITIONING AND ITS CARDIOPROTECTIVE EFFECT IN POST-INTERVENTION CARDIAC REHABILITATION PROGRAMMES FOR PATIENTS WITH CORONARY HEART DISEASE
by: E. S. Karpova, et al.
Published: (2012-08-01)

The Ambivalence of Connexin43 Gap Peptides in Cardioprotection of the Isolated Heart against Ischemic Injury
by: Aleksander Tank Falck, et al.
Published: (2022-09-01)

MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Evaluation of cardioprotection and bio-efficacy enhancement of stevioside and diltiazem in rats
by: Laxit Bhatt, et al.
Published: (2020-07-01)

Evaluation of systolic time intervals in patients of ischemic heart disease with clinical heart failure
by: Smitha Pernaje Seetharam, et al.
Published: (2022-01-01)

Exercise Enhances Branched-Chain Amino Acid Catabolism and Decreases Cardiac Vulnerability to Myocardial Ischemic Injury
by: Guiling Wu, et al.
Published: (2022-05-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

Tankyrase Inhibition Attenuates Cardiac Dilatation and Dysfunction in Ischemic Heart Failure
by: Hong Wang, et al.
Published: (2022-09-01)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis
by: Kayla A. Riggs, et al.
Published: (2022-12-01)

Investigating the association of atopic dermatitis with ischemic stroke and coronary heart disease: A mendelian randomization study
by: Jian Huang, et al.
Published: (2022-08-01)

Endocan is a key player in cardiovascular disease: A review
by: Amina M. Alieva, et al.
Published: (2023-05-01)

In Silico Study of the Mechanisms Underlying the Action of the Snake Natriuretic-Like Peptide Lebetin 2 during Cardiac Ischemia
by: Hinda Allaoui, et al.
Published: (2022-11-01)

Beneficial Effects of Polyphenol-Rich Food Oils in Cardiovascular Health and Disease
by: Lucia Kindernay, et al.
Published: (2023-07-01)

STENOSIS IN NONCORONARY AREAS AND LIFE QUALITY IN ISCHEMIC HEART DISEASE
by: A. N. Sumin, et al.
Published: (2015-07-01)

Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders
by: Daniel P. Jones, et al.
Published: (2018-11-01)

Coming back : a guide to recovering from heart attck /
by: 452460 Cohn, Keith, et al.
Published: (1987)

Concomitant Activation of OSM and LIF Receptor by a Dual-Specific hlOSM Variant Confers Cardioprotection after Myocardial Infarction in Mice
by: Holger Lörchner, et al.
Published: (2021-12-01)

Management of Hypothyroidism in Patients with Acute Myocardial Infarction
by: Danielle Eagan, et al.
Published: (2020-04-01)

Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids: Dichotomy between Experimental and Clinical Studies
by: Melissa Desnoyers, et al.
Published: (2018-07-01)

HELICOBACTER PYLORI AND CARDIOVASCULAR DISEASE: THE ROAD TO THE HEART IS THROUGH THE STOMACH?
by: A. K. Martusevich, et al.
Published: (2012-06-01)

Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways
by: Stefano Piaserico, et al.
Published: (2022-08-01)